Early detection and treatment of ovarian cancer: shifting from early stage to minimal volume of disease based on a new model of carcinogenesis
about
Impact of epithelial ovarian cancer screening on patient-relevant outcomes in average-risk postmenopausal womenUltra-radical (extensive) surgery versus standard surgery for the primary cytoreduction of advanced epithelial ovarian cancerUltraradical surgery for the primary debulking of epithelial ovarian cancerThe Value of Ultrasound Monitoring of Adnexal Masses for Early Detection of Ovarian Cancer.In 2014, can we do better than CA125 in the early detection of ovarian cancer?Emerging role of cancer stem cells in the biology and treatment of ovarian cancer: basic knowledge and therapeutic possibilities for an innovative approachRecent concepts of ovarian carcinogenesis: type I and type IIThe Extracellular Matrix in Epithelial Ovarian Cancer - A Piece of a Puzzle.Autoantibodies to tumor-associated antigens in epithelial ovarian carcinoma.DNA copy numbers profiles in affinity-purified ovarian clear cell carcinomaOncogenic Fli-1 is a potential prognostic marker for the progression of epithelial ovarian cancer.Proteomic biomarkers apolipoprotein A1, truncated transthyretin and connective tissue activating protein III enhance the sensitivity of CA125 for detecting early stage epithelial ovarian cancerThe role of S100A14 in epithelial ovarian tumors.Method for obtaining primary ovarian cancer cells from solid specimensEpithelial membrane protein-2 is a novel therapeutic target in ovarian cancer.Ovarian cancer development and metastasis.Symptom presentation in invasive ovarian carcinoma by tumor histological type and grade in a multiethnic population: a case analysisProteomics analysis for finding serum markers of ovarian cancerChicken pleiotrophin: regulation of tissue specific expression by estrogen in the oviduct and distinct expression pattern in the ovarian carcinomasDiscovery of prognostic factors for diagnosis and treatment of epithelial-derived ovarian cancer from laying hens.Effect of the MDM2 promoter polymorphisms SNP309T>G and SNP285G>C on the risk of ovarian cancer in BRCA1 mutation carriers.Protein biomarkers of ovarian cancer: the forest and the treesEradication of Human Ovarian Cancer Cells by Transgenic Expression of Recombinant DNASE1, DNASE1L3, DNASE2, and DFFB Controlled by EGFR Promoter: Novel Strategy for Targeted Therapy of Cancer.Epithelial ovarian carcinoma types and the coexistence of ovarian tumor conditions.The expression of ribonucleotide reductase M2 in the carcinogenesis of uterine cervix and its relationship with clinicopathological characteristics and prognosis of cancer patients.Chlamydia trachomatis and Mycoplasma genitalium plasma antibodies in relation to epithelial ovarian tumors.Comparison of candidate serologic markers for type I and type II ovarian cancerDetection of the HE4 protein in urine as a biomarker for ovarian neoplasms.Role of histological type on surgical outcome and survival following radical primary tumour debulking of epithelial ovarian, fallopian tube and peritoneal cancers.Breast and ovarian cancers: a survey and possible roles for the cell surface heparan sulfate proteoglycans.Therapeutic strategies in epithelial ovarian cancer.Ovarian Cancer Is an Imported Disease: Fact or Fiction?Differences in Clinical and Biological Features Between Type I and Type II Tumors in FIGO Stages I-II Epithelial Ovarian Carcinoma.Aspirin, nonaspirin nonsteroidal anti-inflammatory drugs, or acetaminophen and risk of ovarian cancerDeepGene: an advanced cancer type classifier based on deep learning and somatic point mutations.Stromal alterations in ovarian cancers via wavelength dependent Second Harmonic Generation microscopy and optical scattering.Transformation of epithelial ovarian cancer stemlike cells into mesenchymal lineage via EMT results in cellular heterogeneity and supports tumor engraftmentc-Met inhibitors attenuate tumor growth of small cell hypercalcemic ovarian carcinoma (SCCOHT) populations.Ovarian cancer : making its own rules-again.Quaternary cytoreductive surgery in ovarian cancer: does surgical effort still matter?
P2860
Q24195062-BA0440B0-4258-4133-A268-60B30BBDA170Q24235043-F4BF2C86-A9E6-41A2-A5DA-228005ACE0C2Q24240766-AD4FF293-AA38-4866-8C42-0AF00D361258Q26767249-15F06051-A539-4BAB-8239-D8591F60C223Q26825152-29E7D388-5645-4130-B5F1-FC4FE484CC6FQ26849477-CC602191-5E09-4F6B-9835-04394C7E3122Q27009487-74C20E6D-519B-4E6A-A558-3CED5512FA8AQ33361929-0F1E22DE-1589-4E4F-A388-3B2C92F6AB8CQ33633387-983AFAC9-9330-443D-AD3D-CA121A2636D3Q33767047-0B1C9AD3-2C73-49E0-BCD2-E3F04FC8058BQ33873793-966C9EE4-375C-4822-B441-67A9E0E92315Q33944027-027055F2-2788-4B1D-B857-9F894EC7F1F3Q33976905-812B8086-5904-4BBE-A506-7618CD16244DQ33978862-1A7EE560-F7AE-4CC4-BD48-9FDEE441A8ADQ34033964-EECAEA66-C070-4C84-B5B3-9E2C9A641C4DQ34086819-6C6BDB9C-F6D4-4058-AC96-DCDD89CBBB9DQ34173704-3BC438AE-BF75-4127-AB62-A3426A7EC9FAQ34182748-F3C80079-8EC0-4E69-BD7F-13750E1A14E4Q34230001-970F3451-F7AD-4499-91CD-9332F42A527CQ34305434-80083112-30E0-4DB4-B0C8-A2930EB6FA9EQ34435034-35A44A70-FD84-4740-8897-EDBCBB605173Q34634143-EC1BBD4A-669E-4ED7-AE79-BF09A1F882D3Q35109273-DCF38989-25DE-4C24-813C-36DCDBAAFCE0Q35116928-27D5F172-6B18-4CE6-A770-3D46AAECB136Q35123132-3A39E23F-55E1-4BCD-83A3-E3BC8B09ECB6Q35137772-3D81C34C-58C2-4CAE-AFF9-6E7EC52AF783Q35154077-3E31961F-E716-49BD-A145-863AFFB6C058Q35166076-7A39BFC1-223C-42A4-99A6-C21BD8CC32CBQ35653923-76B7ED9E-18FB-4052-B424-E1E1CC25749EQ35768137-E221607D-2B39-45B3-AD4D-4358F2174DF0Q35845484-06955374-7BAA-4CCB-AD63-5EBFE8AF61D9Q35878320-FBF9E601-3216-4C35-9A72-4C6401DD1245Q35996897-5D0CC5EE-4554-4DAA-A7E3-CC19DCCDE8B5Q36266504-CC6D92B1-37AC-4B16-9543-8198D42C2650Q36268659-C2E656A0-1D83-46ED-A040-B4CF8F9B7C73Q36272080-E37C77F2-082B-4070-AA70-82CFF4FA92E4Q36434358-EA438513-DE71-4EE9-94E0-59CA213080F0Q36544653-7F8D3758-2A11-4EE8-A9D1-27936F816713Q36557043-1D815EF8-B786-44E9-A6E5-592079B63FF1Q36557877-D26D961C-DF61-4BCC-ADC4-281DE64967D8
P2860
Early detection and treatment of ovarian cancer: shifting from early stage to minimal volume of disease based on a new model of carcinogenesis
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Early detection and treatment ...... a new model of carcinogenesis
@en
type
label
Early detection and treatment ...... a new model of carcinogenesis
@en
prefLabel
Early detection and treatment ...... a new model of carcinogenesis
@en
P2093
P2860
P1476
Early detection and treatment ...... a new model of carcinogenesis
@en
P2093
Ie-Ming Shih
Kala Visvanathan
Richard Roden
Robert J Kurman
P2860
P304
P356
10.1016/J.AJOG.2008.01.005
P407
P577
2008-04-01T00:00:00Z